Hansen Gwenn's Form 4 filing
Nurix Therapeutics, Inc. (NRIX) · filed Jan 4, 2022
- Accession no.
- 0001209191-22-000730
- Filed
- Jan 4, 2022
- Trade date
- Jan 3, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $52.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hansen GwennCIK 0001817160 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Common Stock | MOption exerciseAcquired | +400 | $7.26 | +$2,904 | 14,597 | Direct | |
| Jan 3, 2022 | Common Stock | MOption exerciseAcquired | +1,428 | $9.57 | +$13,665.96 | 16,025 | Direct | |
| Jan 3, 2022 | Common Stock | SSaleDisposed | −1,828 | $28.96 | −$52,938.88 | 14,197 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Common Stock | MOption exerciseDisposed | −400 | $0.00 | $0 | 67,466 | Direct | |
| Jan 3, 2022 | Common Stock | MOption exerciseDisposed | −1,428 | $0.00 | $0 | 81,905 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.